ConductScience.org, home

Paper7523946

A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.

U.S. Multicenter FK506 Liver Study Group. N Engl J Med, 1994. Cited by 785 papers, by iCite.

Cite this record

ConductScience Library. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. Papers, record 7523946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7523946

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.
PubMed
Journal
N Engl J Med
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
785
iCite
Relative citation ratio, by iCite
27.8
iCite
Revised in PubMed
2022-03-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1U.S. Multicenter FK506 Liver Study GroupGroup

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclosporineMajor topic
Immunosuppression TherapyMajor topic
Liver TransplantationMajor topic
TacrolimusMajor topic
Adult
Child
Confidence Intervals
Female
Graft Rejection
Graft Survival
Humans
Liver Diseases
Male

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04657562The New LC-MS/MS Method for Determination of Unbound Tacrolimus in PlasmaBackgroundClinicalTrials.gov
NCT05432765AIIM Trial: Personalized Medicine Approach to Kidney Allograft FunctionResultsClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in7523947Immunosuppression in liver transplantation.https://conductscience.org/library/papers/7523947

Source PubMed

Download CSV of comments and corrections

Cited by183

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 785 citations.

PMIDTitleJournalYearIn PapersSource
42840765Calcineurin inhibitor monitoring in allogeneic hematopoietic cell transplantation: time to move beyond solid organ transplant paradigms.Front Immunol2026https://conductscience.org/library/papers/42840765PubMed
42756046Safety profiles of cyclosporine and tacrolimus in pregnancy: a pharmacovigilance analysis using the FDA Adverse Event Reporting System.Front Med (Lausanne)2026https://conductscience.org/library/papers/42756046PubMed
42609418Tacrolimus Bridging and Combination Therapy Following Infliximab and JAK Inhibitor Failure in Ulcerative Colitis: A Case Series.JGH Open2026https://conductscience.org/library/papers/42609418PubMed
42183236Regulatory T cell therapy in solid organ transplantation: mechanisms, translational progress, and remaining barriers.Front Immunol2026https://conductscience.org/library/papers/42183236PubMed
42073543Anti-Tumor Immunity in Solid-Organ Transplant Recipients.Cancers (Basel)2026https://conductscience.org/library/papers/42073543PubMed
42038742A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP-ALL uncovers novel therapeutic targets.Hemasphere2026https://conductscience.org/library/papers/42038742PubMed
41972119Comparative neuropsychiatric safety signals of tacrolimus versus cyclosporine in solid organ transplantation: ten-year FAERS pharmacovigilance study.Front Immunol2026https://conductscience.org/library/papers/41972119PubMed
41139725Efficacy of Topical Tacrolimus (FK506) in High-risk Penetrating Keratoplasty: A Systematic Review and Meta-analysis of Comparative Studies.Eye (Lond)2025https://conductscience.org/library/papers/41139725PubMed
40980420Population Pharmacokinetic/Pharmacodynamic Modeling of Tacrolimus in Renal Transplant Recipients: Impact of CYP3A5 Genotype and Wuzhi Capsule Co-Medication.Drug Des Devel Ther2025https://conductscience.org/library/papers/40980420PubMed
40647460Immunosuppressant Drug Specific Risk of Malignancy After Organ Transplantation: A Population-Based Analysis of Texas Medicare Beneficiaries.Cancers (Basel)2025https://conductscience.org/library/papers/40647460PubMed
40477053[Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology].Rev Colomb Reumatol2020https://conductscience.org/library/papers/40477053PubMed
39922959Comparison of time-to-event machine learning models in predicting biliary complication and mortality rate in liver transplant patients.Sci Rep2025https://conductscience.org/library/papers/39922959PubMed
39698355Clinical Practice Recommendations on Kidney Management in Methylmalonic Acidemia: an Expert Consensus Statement From ERKNet and MetabERN.Kidney Int Rep2024https://conductscience.org/library/papers/39698355PubMed
39583914
Sublingual Administration of Tacrolimus is Safe and Provides Similar Drug Exposure to Per-oral Route in Liver Transplant Recipients During Early Postoperative Period-A Large, Retrospective, Observational Study.
J Clin Exp Hepatol2025https://conductscience.org/library/papers/39583914PubMed
39509447Ca2+-PP2B-PSD-95 axis: A novel regulatory mechanism of the phosphorylation state of Serine 295 of PSD-95.PLoS One2024https://conductscience.org/library/papers/39509447PubMed
38774214Mechanism of tacrolimus in the treatment of lupus nephritis.Front Pharmacol2024https://conductscience.org/library/papers/38774214PubMed
38590090Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort Study.Ann Transplant2024https://conductscience.org/library/papers/38590090PubMed
38495462Rejection in Liver Transplantation Recipients.J Clin Exp Hepatol2024https://conductscience.org/library/papers/38495462PubMed
38450290Basics and Art of Immunosuppression in Liver Transplantation.J Clin Exp Hepatol2024https://conductscience.org/library/papers/38450290PubMed
37693257Drug Interactions and Safe Prescription Writing for Liver Transplant Recipients.J Clin Exp Hepatol2023https://conductscience.org/library/papers/37693257PubMed

See all 183 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7523946

GET https://conductscience.org/api/papers/v1/7523946/cited_by?page=2